Form 8-K - Current report:
SEC Accession No. 0001387131-17-003696
Filing Date
2017-07-20
Accepted
2017-07-20 08:50:21
Documents
2
Period of Report
2017-07-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_072017.htm 8-K 30026
2 FORM OF WARRANT REPRICING LETTER AGREEMENT ex10-1.htm EX-10.1 33594
  Complete submission text file 0001387131-17-003696.txt   64937
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 17973452
SIC: 2834 Pharmaceutical Preparations